Description
LinATAB E 5/10 mg is a combination medication that contains linagliptin and metformin, used in the management of type 2 diabetes mellitus. Linagliptin is a DPP-4 inhibitor that helps increase insulin secretion and decrease glucagon levels, while metformin improves insulin sensitivity and reduces hepatic glucose production. This dual action effectively helps lower blood sugar levels and improve glycemic control in patients with type 2 diabetes. The 5/10 mg dosage indicates the specific strengths of each active ingredient, allowing for tailored treatment based on individual patient needs. LinATAB E is typically prescribed as part of a comprehensive diabetes management plan that includes diet and exercise. Patients should follow their healthcare provider's instructions for optimal results and to minimize the risk of side effects.
.jpeg)
.jpg)
.png)
.jpg)
.webp)
.jpeg)
.jpg)
.jpg)
.webp)
.jpg)
 400MG.jpg)
.jpg)
.jpg)
.jpeg)
.jpeg)
.jpg)
 100 IU 3 ML.webp)
.webp)
Change Language